{"SPADE_N_05426": {"Clinical Information": [{"Medical use": "Gram-positive infections,MRSA", "Company": "Novacta Biosystems Ltd.(Hatfield, England)", "Stage of Development": "Preclinical", "Comments": "No more comments", "Clinical Trials": []}], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_05426", "Peptide Name": "Mersacidin (Bacteriocin; Preclinical)", "Source": "Bacillus sp. HIL-Y85/54728 (Gram-positive bacteria)", "Family": "Belongs to the type B lantibiotic family (Class I bacteriocin)", "Gene": "mrsA", "Sequence": "CTFTLPGGGGVCTLTSECIC", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/P43683"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive bacteria:Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, Clostridium difficile.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "The sugar phosphate head group of the peptidoglycan precursorLipid II", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C81H132N20O28S4", "Mass": 1962.29, "PI": 4.05, "Net Charge": -1, "Hydrophobicity": 0.94, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Function": "Kills a number of Gram-positive bacteria. Acts at the level of cell wall biosynthesis by interfering with bacterial peptidoglycan biosynthesis. Specifically inhibits the conversion of the lipid II intermediate into polymeric nascent glycan strands by transglycosylation. May interact with the peptidoglycan precursor rather than with the enzyme.", "PTM": "There are one dihydroalanine (Dha)", "Literature": [{"Title": "Cloning, sequencing and production of the lantibiotic mersacidin.", "Pubmed ID": "7737474", "Reference": "FEMS Microbiol Lett. 1995 Mar 15;127(1-2)121-126.", "Author": "Bierbaum G, Brötz H, Koller KP, Sahl HG.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=7737474"}, {"Title": "Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.", "Pubmed ID": "9119018", "Reference": "Eur J Biochem. 1997 Mar 1;244(2)501-512.", "Author": "Prasch T, Naumann T, Markert RL, Sattler M, Schubert W, Schaal S, Bauch M, Kogler H, Griesinger C.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=9119018"}, {"Title": "Biosynthesis of the lantibiotic mersacidin organization of a type B lantibiotic gene cluster.", "Pubmed ID": "10831439", "Reference": "Appl Environ Microbiol. 2000 Jun;66(6)2565-2571.", "Author": "Altena K, Guder A, Cramer C, Bierbaum G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10831439"}, {"Title": "Ab initio structure determination of the lantibiotic mersacidin.", "Pubmed ID": "10818347", "Reference": "Acta Crystallogr D Biol Crystallogr. 2000 Jun;56(Pt 6)705-713.", "Author": "Schneider TR, Kärcher J, Pohl E, Lubini P, Sheldrick GM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10818347"}], "Frequent Amino Acids": "CGT", "Absent Amino Acids": "ADHKMNOQRUWY", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 10, "Positive Residues": 0, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06102", "Similarity": 1.0, "Sequence": "MSQEAIIRSWKDPFSRENSTQNPAGNPFSELKEAQMDKLVGAGDMEAACTFTLPGGGGVCTLTSECIC"}, {"SPADE_ID": "SPADE_N_15254", "Similarity": 1.0, "Sequence": "CTFTLPGGGGVCTLTECIC"}, {"SPADE_ID": "SPADE_UN_01709", "Similarity": 1.0, "Sequence": "GGGG"}]}}}